Evidence map›Paper›PMID 41703060›Full record

ReviewRadiologie (Heidelberg, Germany)2026

[Positron emission tomography in sarcomas].

Wolfgang P Fendler, Lukas Kessler, Stephan Himmen, Rainer Hamacher

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Radiologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wolfgang P FendlerKlinik für Nuklearmedizin, Westdeutsches Krebszentrum, DKTK und NCT-Standort, Universitätsklinikum Essen, Hufelandstraße 55, 45147, Essen, Deutschland. wolfgang.fendler@uk-essen.de.
Lukas KesslerKlinik für Nuklearmedizin, Westdeutsches Krebszentrum, DKTK und NCT-Standort, Universitätsklinikum Essen, Hufelandstraße 55, 45147, Essen, Deutschland.
Stephan HimmenKlinik für Nuklearmedizin, Westdeutsches Krebszentrum, DKTK und NCT-Standort, Universitätsklinikum Essen, Hufelandstraße 55, 45147, Essen, Deutschland.
Rainer HamacherMedizinische Onkologie, Westdeutsches Krebszentrum, Universitätsklinikum Essen, Essen, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcomas are rare, heterogeneous tumors of mesenchymal origin. Molecular imaging is crucial for diagnosis, staging, and therapy monitoring. NEW IMAGING METHODS AND THERAPY: Fibroblast activation protein (FAP) is expressed at high concentrations in many sarcomas, often directly on the tumor cells themselves as well as on cancer-associated fibroblasts. FAP is therefore an attractive target for molecular imaging and therapy. OUTLOOK: Further prospective studies are needed to evaluate and establish the role of

Indexed as

Positron Emission Tomography Computed TomographySarcomaBone NeoplasmsFibroblast Activation Protein AlphaFluorodeoxyglucose F18HumansRadiopharmaceuticalsSerine EndopeptidasesFibroblast Activation Protein AlphaFluorodeoxyglucose F18RadiopharmaceuticalsSerine EndopeptidasesFibroblast activation proteinMolecular imagingRadioligand therapyRare tumorsStandardized uptake value

Identifiers

PMID41703060

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.